MSHPX
Price
$12.89
Change
+$0.13 (+1.02%)
Updated
Dec 20 closing price
VIGIX
Price
$214.82
Change
+$2.24 (+1.05%)
Updated
Dec 20 closing price
Ad is loading...

MSHPX vs VIGIX

Header iconMSHPX vs VIGIX Comparison
Open Charts MSHPX vs VIGIXBanner chart's image
Morgan Stanley Inst Permanence R6
Price$12.89
Change+$0.13 (+1.02%)
VolumeN/A
CapitalizationN/A
Vanguard Growth Index Institutional
Price$214.82
Change+$2.24 (+1.05%)
VolumeN/A
CapitalizationN/A
MSHPX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSHPX vs. VIGIX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSHPX is a Sell and VIGIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 282B vs. MSHPX (4.7M). VIGIX pays higher dividends than MSHPX: VIGIX (0.53) vs MSHPX (0.00). MSHPX was incepted earlier than VIGIX: MSHPX (5 years) vs VIGIX (27 years). MSHPX is a more actively managed with annual turnover of: 100.00 vs. VIGIX (5.00). MSHPX (5000000) and VIGIX (5000000) have matching initial minimum investment requirements. VIGIX annual gain was more profitable for investors over the last year : 34.37 vs. MSHPX (3.80).
MSHPXVIGIXMSHPX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years27 years-
Gain YTD3.47534.27210%
Front LoadN/AN/A-
Min. Initial Investment50000005000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets4.7M282B0%
Annual Yield % from dividends0.000.53-
Returns for 1 year3.8034.3711%
Returns for 3 years-5.9332.77-18%
Returns for 5 yearsN/A129.76-
Returns for 10 yearsN/A298.58-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCL238.437.67
+3.32%
Royal Caribbean Group
ATUS2.640.08
+3.13%
Altice USA
CCCC3.950.11
+2.73%
C4 Therapeutics
PFSI101.661.56
+1.56%
PennyMac Financial Services
ELEV0.58-0.05
-7.30%
Elevation Oncology